BioPharmSignal logoBioPharmSignal

Biotech News

PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results

PAVmed (PAVM)PAVmedEarnings

PAVM (PAVM) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is pavm.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Related news

PAVMPAVmed2026-07-31 12:30 EST

PAVmed to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 14, 2026

PAVMPAVmed2026-07-30 12:30 EST

Lucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 13, 2026

AEMDAethlon Medical2026-08-05 12:01 EST

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026

DNLIDenali Therapeutics2026-08-06 20:01 EST

Denali Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights

CVRXCVRx2026-08-06 20:05 EST

CVRx Reports Second Quarter 2026 Financial and Operating Results

PLSEPulse Biosciences2026-08-06 20:05 EST

Pulse Biosciences Reports Business Updates and Second Quarter 2026 Financial Results

ACHCAcadia Healthcare2026-07-28 20:05 EST

Acadia Healthcare Announces Second Quarter 2026 Results and Updates Full Year 2026 Financial and Cash Flow Guidance

STIMNeuronetics2026-07-28 12:30 EST

Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call

DNLIDenali Therapeutics2026-07-27 20:01 EST

Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026

CVRXCVRx2026-07-23 20:30 EST

CVRx to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call on August 6, 2026

View all latest news

PAVmed

PAVmed is a medical device and commercialization platform company focused on building and launching healthcare products. Its business is more about commercialization and device execution than biotech.

Recent company news

PAVMPAVmed2026-08-05 12:46 EST

Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test

PAVMPAVmed2026-08-04 12:30 EST

Lucid Diagnostics to Participate in Upcoming Investor Conferences

PAVMPAVmed2026-07-31 12:30 EST

PAVmed to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 14, 2026

PAVMPAVmed2026-07-30 12:30 EST

Lucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 13, 2026

PAVMPAVmed2026-05-15 12:00 EST

PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results

Stock data

Close
4.94 USD
Market cap
42.95M USD
Exchange
NASDAQ
Sector
MedTech
Location
United States